Physician profile

Christina M Salcher

Foot & Ankle Surgery · Mckinney, TX

NPI 1871741892

$546.38

in general payments reported to CMS, 2019-2025

7 companies · $8.50 in 2025

See the full distribution for Foot & Ankle Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$69.76

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Integra Lifesciences Corporation $258.45 2021
Smith+Nephew, INC. $189.63 2022-2024 Collagenase Santyl
Depuy Synthes Sales INC. $47.45 2021-2023 Motoband
Organogenesis INC. $16.89 2023 Puraply
Glaxosmithkline, LLC. $13.05 2020
Musculoskeletal Transplant Foundation INC. $12.41 2021
Orthofix Medical, INC. $8.50 2025 Physio-Stim

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christina M Salcher

$546.38

in general payments reported 2019-2025

Years
2020-2025
Top company
Integra Lifesciences Corporation

https://glasscript.com/doctor/673200/christina-m-salcher

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.